MDM1EA

Pharmaceutical compound From Wikipedia, the free encyclopedia

N-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine (MDM1EA), also known as α,N-dimethyl-3,4-methylenedioxybenzylamine (α,N-DMMDBA) or as α,N-dimethylpiperonylamine, is an entactogen-like drug of the benzylamine family related to MDMA.[1][2][3] It is the analogue of MDMA in which the side chain has been shortened by one carbon atom.[1][2][3]

Other namesN-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine; MDM1EA; α,N-Dimethyl-3,4-methylenedioxybenzylamine; α,N-DMMDBA; α,N-Dimethylpiperonylamine; α,N-Dimethyl-1,3-benzodioxole-5-methanamine
CAS Number
Quick facts Clinical data, Other names ...
MDM1EA
Clinical data
Other namesN-Methyl-1-(3,4-methylenedioxyphenyl)-1-ethanamine; MDM1EA; α,N-Dimethyl-3,4-methylenedioxybenzylamine; α,N-DMMDBA; α,N-Dimethylpiperonylamine; α,N-Dimethyl-1,3-benzodioxole-5-methanamine
Identifiers
  • 1-(1,3-benzodioxol-5-yl)-N-methylethanamine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H13NO2
Molar mass179.219 g·mol−1
3D model (JSmol)
  • CC(C1=CC2=C(C=C1)OCO2)NC
  • InChI=1S/C10H13NO2/c1-7(11-2)8-3-4-9-10(5-8)13-6-12-9/h3-5,7,11H,6H2,1-2H3
  • Key:USAUUVXZKYYZIL-UHFFFAOYSA-N
Close

The drug has been found to be a weak serotonin reuptake inhibitor and partially substituted for MDMA in rodent drug discrimination tests at the highest assessed doses.[1][2][4][3] The effects of α,N-DMMDBA in humans are unknown.[1]

It is not a controlled substance in the United States as of 2011.[1]

Homo-MDMA (HMDMA), an analogue of MDMA in which the side chain was extended by one carbon atom, has also been synthesized and studied.[2][3] It partially substituted for MDMA similarly to MDM1EA.[2][3]

See also

References

Related Articles

Wikiwand AI